109 related articles for article (PubMed ID: 32516548)
41. The lncRNA HOXA11-AS regulates Rab3D expression by sponging miR-125a-5p promoting metastasis of osteosarcoma.
Cao K; Fang Y; Wang H; Jiang Z; Guo L; Hu Y
Cancer Manag Res; 2019; 11():4505-4518. PubMed ID: 31191012
[No Abstract] [Full Text] [Related]
42. MARK1 is a Novel Target for miR-125a-5p: Implications for Cell Migration in Cervical Tumor Cells.
Natalia MA; Alejandro GT; Virginia TJ; Alvarez-Salas LM
Microrna; 2018; 7(1):54-61. PubMed ID: 29076440
[TBL] [Abstract][Full Text] [Related]
43. Circ_0000069 contributes to the growth, metastasis and glutamine metabolism in renal cell carcinoma (RCC) via regulating miR-125a-5p-dependent SLC1A5 expression.
Yang L; Wang L; Wu J; Wang Y
Transpl Immunol; 2023 Apr; 77():101764. PubMed ID: 36462557
[TBL] [Abstract][Full Text] [Related]
44. Down-Regulated miR-125a-5p Promotes the Reprogramming of Glucose Metabolism and Cell Malignancy by Increasing Levels of CD147 in Thyroid Cancer.
Huang P; Mao LF; Zhang ZP; Lv WW; Feng XP; Liao HJ; Dong C; Kaluba B; Tang XF; Chang S
Thyroid; 2018 May; 28(5):613-623. PubMed ID: 29634399
[TBL] [Abstract][Full Text] [Related]
45. miR-125a-5p-targeted regulation of TRA2β expression inhibits proliferation and metastasis of hepatocellular carcinoma cells.
Zhou J; Wang L; Cui Y; Tang L
Am J Transl Res; 2021; 13(12):14074-14080. PubMed ID: 35035750
[TBL] [Abstract][Full Text] [Related]
46. Overexpression of hsa-miR-125a-5p enhances proliferation, migration and invasion of head and neck squamous cell carcinoma cell lines by upregulating C-C chemokine receptor type 7.
Jin S; Liu MD; Wu H; Pang P; Wang S; Li ZN; Sun CF; Liu FY
Oncol Lett; 2018 Jun; 15(6):9703-9710. PubMed ID: 29928346
[TBL] [Abstract][Full Text] [Related]
47. Tanshinone IIA protects motor neuron-like NSC-34 cells against lipopolysaccharide-induced cell injury by the regulation of the lncRNA TCTN2/miR-125a-5p/DUSP1 axis.
Yan Q; Xun Y; Lei D; Zhai H
Regen Ther; 2023 Dec; 24():417-425. PubMed ID: 37727797
[TBL] [Abstract][Full Text] [Related]
48. MiR-125a-5p inhibits the proliferation and invasion of breast cancer cells and induces apoptosis by targeting GAB2.
Wang LB; Feng L; He J; Liu B; Sun JG
Math Biosci Eng; 2019 Jul; 16(6):6923-6933. PubMed ID: 31698596
[No Abstract] [Full Text] [Related]
49. Long Noncoding RNA Cytoskeleton Regulator RNA Suppresses Apoptosis in Hepatoma Cells by Modulating the miR-125a-5p/HS1-Associated Protein X-1 Axis to Induce Caspase-9 Inactivation.
Wu ZY; Wang Y; Hu H; Ai XN; Zhang Q; Qin YG
Gut Liver; 2023 Nov; 17(6):916-925. PubMed ID: 36700300
[TBL] [Abstract][Full Text] [Related]
50. lncRNA CERS6-AS1 as ceRNA promote cell proliferation of breast cancer by sponging miR-125a-5p to upregulate BAP1 expression.
Yan L; Li K; Feng Z; Zhang Y; Han R; Ma J; Zhang J; Wu X; Liu H; Jiang Y; Zhang Y; Zhu Y
Mol Carcinog; 2020 Oct; 59(10):1199-1208. PubMed ID: 32808708
[TBL] [Abstract][Full Text] [Related]
51. Exosomal encapsulation of miR-125a-5p inhibited trophoblast cell migration and proliferation by regulating the expression of VEGFA in preeclampsia.
Xueya Z; Yamei L; Sha C; Dan C; Hong S; Xingyu Y; Weiwei C
Biochem Biophys Res Commun; 2020 May; 525(3):646-653. PubMed ID: 32122654
[TBL] [Abstract][Full Text] [Related]
52. MicroRNA-125a-5p regulates cancer cell proliferation and migration through NAIF1 in prostate carcinoma.
Fu Y; Cao F
Onco Targets Ther; 2015; 8():3827-35. PubMed ID: 26719710
[TBL] [Abstract][Full Text] [Related]
53. MIR600HG sponges miR-125a-5p to regulate glycometabolism and cisplatin resistance of oral squamous cell carcinoma cells via mediating RNF44.
Liu X; Zhao T; Yuan Z; Ge S
Cell Death Discov; 2022 Apr; 8(1):216. PubMed ID: 35443748
[TBL] [Abstract][Full Text] [Related]
54. miR-125a-5p upregulation suppresses the proliferation and induces the cell apoptosis of lung adenocarcinoma by targeting NEDD9.
Zheng H; Wu J; Shi J; Lu C; Wang Y; Sun Q; Zhang G; Zhao G
Oncol Rep; 2017 Sep; 38(3):1790-1796. PubMed ID: 28714018
[TBL] [Abstract][Full Text] [Related]
55. EZH2 is involved in psoriasis progression by impairing miR-125a-5p inhibition of SFMBT1 and leading to inhibition of the TGFβ/SMAD pathway.
Qu S; Liu Z; Wang B
Ther Adv Chronic Dis; 2021; 12():2040622320987348. PubMed ID: 33948156
[TBL] [Abstract][Full Text] [Related]
56. miR-125a-5p inhibits the expression of NLRP3 by targeting CCL4 in human vascular smooth muscle cells treated with ox-LDL.
Wang J; Wu Q; Yu J; Cao X; Xu Z
Exp Ther Med; 2019 Sep; 18(3):1645-1652. PubMed ID: 31410121
[TBL] [Abstract][Full Text] [Related]
57. Prognostic and clinicopathologic significance of MicroRNA-125a-5p in cancers: A meta-analysis.
Ye H; Zhu W; Mei L; Lu Z
Medicine (Baltimore); 2019 Aug; 98(31):e16685. PubMed ID: 31374052
[TBL] [Abstract][Full Text] [Related]
58. Downregulation of
Shishavan NS; Sasani ST; Salehi Z; Azhang MR
Microrna; 2022; 11(3):263-270. PubMed ID: 36082867
[TBL] [Abstract][Full Text] [Related]
59. MicroRNA-125a-5p modulates human cervical carcinoma proliferation and migration by targeting ABL2.
Qin X; Wan Y; Wang S; Xue M
Drug Des Devel Ther; 2016; 10():71-9. PubMed ID: 26766902
[TBL] [Abstract][Full Text] [Related]
60. Curcumin exerts inhibitory effects on undifferentiated nasopharyngeal carcinoma by inhibiting the expression of miR-125a-5p.
Gao W; Chan JY; Wong TS
Clin Sci (Lond); 2014 Nov; 127(9):571-9. PubMed ID: 24896104
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
